Eating on GLP-1 Medications vs Ketogenic (Keto) Diet

Eating on GLP-1 MedicationsProtein-dense foods prioritized first at each meal (eggs, dairy, poultry, fish, tofu, legumes, protein supplements); smaller, more frequent meals; adequate fiber and fluids.

Ketogenic (Keto) DietOlive and avocado oil, butter, fatty fish (salmon, sardines), eggs, cheese, nuts and seeds, avocado, poultry and beef, low-carb vegetables (leafy greens, broccoli, cauliflower, zucchini, peppers).

Eating on GLP-1 MedicationsHigh-fat, greasy, or fried foods (they slow gastric emptying further and are a common nausea trigger); large meals in general.

Ketogenic (Keto) DietBread, rice, pasta, cereal, sugar and sweets, most fruit, potatoes, corn, legumes, most milk.

Eating on GLP-1 MedicationsSmaller, more frequent meals rather than a few large ones — recommended specifically to manage nausea from delayed gastric emptying, not a fixed window or schedule.

Ketogenic (Keto) DietNo specific eating window — defined by macro ratios, not meal timing.

Eating on GLP-1 MedicationsPreserve lean muscle mass and manage GI side effects while eating much less food overall.

Ketogenic (Keto) DietWeight loss / ketosis-driven metabolic shift (clinically, epilepsy management).

Eating on GLP-1 MedicationsPeople on GLP-1/GIP receptor agonist medications (semaglutide, tirzepatide, and similar) needing to close protein, fiber, and micronutrient gaps despite a much smaller appetite.

Ketogenic (Keto) DietPeople who do well with firm food-category rules and don’t mind cutting out entire food groups, more than people wanting a flexible, indefinitely sustainable pattern.

Eating on GLP-1 MedicationsHigh protein emphasis — 1.6–2.3 g protein per kg of fat-free mass daily (well above the 0.8 g/kg RDA), alongside resistance training.

Ketogenic (Keto) DietVery high fat (70–80%), low protein (10–20%), very low carb (5–10%, roughly 20–50g net carbs/day).

Eating on GLP-1 MedicationsSpecifically for people on GLP-1/dual GIP-GLP-1 receptor agonist medications; addresses lean-mass loss (up to roughly 25% of weight lost is lean mass per SURMOUNT-1) and GI side effects (40–70% of patients).

Ketogenic (Keto) DietOriginally developed for drug-resistant epilepsy (still in clinical use); not recommended without medical guidance for pancreatitis, liver or gallbladder disease, certain kidney conditions, pregnancy, or insulin/SGLT2-inhibitor use.

Eating on GLP-1 MedicationsStrong for the underlying mechanisms cited — DXA-based body-composition substudies (SURMOUNT-1, STEP 1) and clinical reviews, though the page notes a general lack of structured nutrition guidance for GLP-1 patients.

Ketogenic (Keto) DietLimited long-term advantage — meta-analyses show short-term benefits similar to other calorie-restricted diets but no clear long-term edge, with real adherence and safety caveats (LDL increases in some people, dropout as high as 54–91% in some trial arms).

Eating on GLP-1 MedicationsLow in food-type terms — no foods banned; the main constraint is a sharply reduced total food volume, which raises the risk of nutrient shortfalls.

Ketogenic (Keto) DietHigh — cuts entire food groups; trial dropout reached over half of participants in some studies.

Eating on GLP-1 MedicationsPrioritizing protein-dense foods at every meal, and sometimes a protein supplement, to hit intake targets on a much smaller food volume can add cost on top of the medication itself.

Ketogenic (Keto) DietCost varies widely depending on execution: built on everyday meat, eggs, and vegetables it's comparably priced to a standard diet, but relying on specialty low-carb products like keto bread, pasta, or meal-replacement shakes adds a substantial premium over the same diet made with whole foods.